Aug 11, 2026 04:56PM
Aug 11, 2026 04:05PM
Aug 5, 2026 08:30AM
Aug 5, 2026 08:30AM
May 22, 2026 05:18PM
May 13, 2026 05:20PM
May 13, 2026 04:05PM Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
Apr 23, 2026 04:13PM
Apr 2, 2026 08:33AM
Apr 2, 2026 08:30AM
Mar 26, 2026 05:15PM
Mar 10, 2026 08:32AM
Mar 10, 2026 08:30AM
Mar 5, 2026 09:00AM Dermata Opens a New Chapter with the Release of Tome Skincare
Jan 20, 2026 08:05AM
Jan 20, 2026 08:05AM
Dec 29, 2025 04:05PM
Dec 29, 2025 04:05PM
Dec 24, 2025 08:00AM
Dec 24, 2025 08:00AM
Dec 4, 2025 08:00AM A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
Nov 14, 2025 05:28PM
Nov 14, 2025 04:05PM
Oct 2, 2025 08:02AM
Oct 2, 2025 08:00AM
Sep 17, 2025 01:00AM
Sep 10, 2025 08:01AM
Sep 10, 2025 08:00AM Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments
Aug 13, 2025 05:44PM
Aug 13, 2025 05:00PM
Jul 8, 2025 08:01AM
Jul 8, 2025 08:00AM
May 21, 2025 07:54AM
May 14, 2025 09:00AM
Apr 15, 2025 08:35AM Dermata's (DRMA) XYNGARI Phase 3 trial shows significant difference
Apr 15, 2025 08:30AM
Mar 27, 2025 08:15PM
Mar 27, 2025 08:01AM
Mar 27, 2025 07:55AM
Mar 17, 2025 04:16PM
Feb 25, 2025 07:59AM
Feb 25, 2025 07:58AM Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Botulinum Toxin Treatment for Hyperhidrosis
Jan 29, 2025 04:05PM
Jan 23, 2025 04:15PM
Jan 22, 2025 08:04AM
Jan 22, 2025 08:00AM
Jan 21, 2025 08:03AM
Jan 21, 2025 08:00AM
Dec 16, 2024 09:00AM Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)
Dec 10, 2024 09:08AM

433,990 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All